- Home
- SGA vs ZTEK Comparison
SGA vs ZTEK Comparison
Compare SGA & ZTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SGA | ZTEK |
|---|---|---|
| Founded | 1986 | 2008 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Broadcasting | Major Chemicals |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 73.3M | 78.2M |
| IPO Year | 1992 | N/A |
Fundamental Metrics
Financial Performance| Metric | SGA | ZTEK |
|---|---|---|
| Price | $11.40 | $0.84 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 13.7K | ★ 94.4K |
| Earning Date | 03-10-2026 | 02-27-2026 |
| Dividend Yield | ★ 8.84% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.05 | N/A |
| Revenue | ★ $109,822,000.00 | $657,134.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.53 | N/A |
| P/E Ratio | $236.99 | ★ N/A |
| Revenue Growth | N/A | ★ 2225.73 |
| 52 Week Low | $10.68 | $0.62 |
| 52 Week High | $14.27 | $1.84 |
Technical Indicators
Market Signals| Indicator | SGA | ZTEK |
|---|---|---|
| Relative Strength Index (RSI) | 47.95 | 55.39 |
| Support Level | $10.75 | $0.85 |
| Resistance Level | $11.66 | $1.09 |
| Average True Range (ATR) | 0.34 | 0.08 |
| MACD | 0.04 | 0.02 |
| Stochastic Oscillator | 50.38 | 47.22 |
Price Performance
Historical ComparisonAbout SGA Saga Communications Inc. (FL)
Saga Communications Inc is a broadcast company engaged in acquiring, developing, and operating broadcast properties. The company's objective is to operate top billing radio stations in mid-sized markets. It derives a majority of its revenue from the sale of advertising for broadcast on its stations.
About ZTEK Zentek Ltd.
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.